Figure 3From: Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapyEffects of anti-TNF-alpha therapy on the levels of progenitor cell phenotypes and clinical severity. ESR, CRP, VAS and progenitor cell phenotypes were measured at baseline and after 3 and 6 months in 8 children with persistently active JIA. In 3 individuals, a blood sample was also performed at 12 months. *p < 0.05 versus baseline.Back to article page